# Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/combined-radiotherapy-and-anti-pd-l1-antibody-synergistically-enhances-antitumor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xiaomei Gong,Xuefei Li,Tao Jiang,Huikang Xie,Zhengfei Zhu,Fei Zhou,Caicun Zhou |
| Citations | 306 |
| DOI | 10.1016/j.jtho.2017.04.014 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2610224116 |
| PMID | 28478231 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Zhengfei Zhu](https://scholariq.org/researchers/zhengfei-zhu/)
- [Tao Jiang](https://scholariq.org/researchers/tao-jiang/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Effects of Radiation Exposure](https://scholariq.org/topics/effects-of-radiation-exposure/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.